The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia

References

• Bleul C C, Fulbrigge R C, Casanovas J M, Aluti A, Springer T A. A highly efficacious lymphocyte chemotractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996; 184: 1101–1109
   PubMed Web of Science ®Google Scholar
• Aluti A, Webb I J, Bleul C, Springer T, Gutierrez-Ramos J C. The chemokine SDF-1 is a chemoattractant for human CD34 + haemopoietic progenitor cells and provides a new mechanism to explain the mobilisation of CD34 + progenitors to peripheral blood. J Exp Med 1997; 185: 111–120
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Borggesani P R, Segal R A, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis and derailed cerebellar neuron migration in CXCR4 and SDF-1 deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448–9453
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Springer T A. The chemokine receptor CXCR4 is required for the retention of b lineage and granulocytic precursors within the bone marrow microenviroment. Immunity 1999; 10: 463–471
   PubMed Web of Science ®Google Scholar
• Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001; 12: 313–335
   PubMed Web of Science ®Google Scholar
• Hargreaves D C, Hyman P L, Lu T T, Ngo V N, Bidgul A, Suzuki G, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001; 194: 45–56
   PubMed Web of Science ®Google Scholar
• Wehrli N, Legler D F, Finke D, Toellner K M, Loetscher P, Baggiolini M, et al. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol 2001; 31: 609–616
   PubMed Web of Science ®Google Scholar
• Ganju R K, Brubaker S A, Meyer J, Dutt P, Yang Y, Qin S, et al. The α-chemokine stromal cell-derived factor 1α binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998; 273: 23169–23175
   PubMed Web of Science ®Google Scholar
• Chernock R D, Cherla R P, Ganju R K. SHP2 and cbl participate in α-chemokine receptor CXCR4 mediated signalling pathways. Blood 2001; 97: 608–615
   PubMed Web of Science ®Google Scholar
• Oh S B, Endoh T, Simen A A, Ren D, Miller R J. Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 2002; 123: 66–75
   PubMed Web of Science ®Google Scholar
• Kijowski J, Bay-Kryzworzeka M, Majka M, Reca R, Marquez L A, Christofidou-Solomidou M, et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohaemopoietic cells. Stem Cells 2001; 19: 453–466
   PubMed Web of Science ®Google Scholar
• Schen W, Bendall L J, Gottleib D J, Bradstock K F. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukaemic precursor-B cells in the bone marrow. Exp Haematol 2001; 29: 1439–1447
   PubMed Web of Science ®Google Scholar
• Burger J A, Burger M, Kipps T J. Chronic lymphocytic leukaemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999; 94: 3658–3667
   PubMed Web of Science ®Google Scholar
• Burger J A, Tsukada N, Burger M, Zvaifler N J, Dell'Aquila M, Kipps T J. Blood-derived nurse-like cells protect chronic lymphocytic B cells from spontaneous apoptosis through stromal cell-derived factor. Blood 2000; 96: 2655–2663
   PubMed Web of Science ®Google Scholar
• Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Gupta D, et al. The biologic sequelae of stromal cell-derived factor 1 alpha in multiple myeloma. Mol Cancer Ther 2002; 1: 539–544
   PubMed Web of Science ®Google Scholar
• Sanz-Rodriguez F, Hidalgo A, Teixido J. Chemokine stromal cell-derived factor 1 alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 2001; 97: 346–351
   PubMed Web of Science ®Google Scholar
• Hideshima T, Nakamura N, Chauhan D, Anderson K C. Biologic sequelae of interleukin-6 induced PI3-K/Akt signalling in multiple myeloma. Oncogene 2001; 20: 5991–6000
   PubMed Web of Science ®Google Scholar
• Podar K, Tai Y T, Davies F E, Lewtzsch S, Saftler M, Hideshima T, et al. Vascular endothelial growth factor triggers signalling cascades mediating multiple myeloma cell growth and migration. Blood 2001; 98: 428–435
   PubMed Web of Science ®Google Scholar
• Winkler C, Modi W, Smith M W, Nelson G W, Wu X, Carrington M, et al. Genetic restriction of AIDS pathogenesis by a SDF-1 chemokine gene variant. Science 1998; 118: 681–688
   Google Scholar
• Rabkin C S, Yang Q, Goerdet J J, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999; 93: 1838–1842
   PubMed Web of Science ®Google Scholar
• de Oliviera Cavassin G G, de Luca F L, Andre N G, Covas D T, Pelegrinelli Fungaro M H, Voltarelli J C, et al. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis 2004; 33: 90–93
   PubMed Web of Science ®Google Scholar
• Binet J L, Auquier A, Dighiero G, Chastang C, Piquet H, Goasquen J, et al. A new prognostic classification of chronic lymphocytic leukaemia derived from multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S R, et al. National cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, et al. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Br J Haematol 2004; 125: 294–317
   PubMed Web of Science ®Google Scholar
• Smith A, Behrens J, Drayson M, Iggo N, Jackson G, Liddi J, et al. Diagnosis and management of multiple myeloma. Br J Haematol 2001; 115: 522–540
   PubMed Web of Science ®Google Scholar
• Kelly K, Durie B, MacLennan I CM. Prognostic factors and staging system for myeloma: comparisons between the MRC studies in the United Kingdom and the Southwest Oncology Group studies in the United States. Haematol Oncol 1998; 6: 182–185
   Google Scholar
• Kaplan E L, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient II. Analysis and example. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Regression models and life tables. Cox DR J Roy Stat Soc 1972; 34: 187–220
   Google Scholar
• Barretina J, Junca J, Llano A, Guttierrez A, Flores A, Blanco J, et al. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukaemia and stage of disease. Ann Haematol 2003; 82: 500–505
   PubMed Web of Science ®Google Scholar
• Ghobrial I M, Bone N D, Stenson M J, Novak A, Hedin K E, Kay N E, et al. Expression of the chemokine receptor CXCR4 and CCR7 and disease preogression in B-cell chronic lymphocytic leukaemia/small lymphocytic leukaemia. Mayo Clin Proc 2004; 79: 318–325
   PubMed Web of Science ®Google Scholar
• Lopez-Giral S, Quintana N E, Cabreizo M, Alfonso-Perez M, Sala V M, De Soria V G, et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with nodular dissemination. J Leukoc Biol 2004; 76: 462–471
   PubMed Web of Science ®Google Scholar